Skip til primært indhold


Choice of radiation dose

This is an English translation of the danish ”Valg af stråledosis” patient decision aid. Concerns patients planned to receive high dose stereotactic body radiation therapy for a tumor In the lung located less than 1 cm from the thoracic wall. The patients will be able to choose either high or lower radiation dose. A lower dose will decrease the risk of side effects, but local tumor control might also be decreased. The Danish patient decision aid is being tested in a local randomized trial, SDM Lung SBRT

Subject area   

Treatment, lung cancer or lung metastasis from another primary cancer


  • High dose, 66 Gray in 3 fractions
  • Lower dose, 45 Gray in 3 fractions
  • No treatment
  • High dose, 66 Gray in 3 fractions, pall
  • Lover dose, 45 Gray in 3 fractions, pall
  • No treatment (pall)

Preparation sheet included 


Developed by

Department of Oncology, Lillebaelt Hospital in collaboration with CFFB

Responsible for update 

Physician, PhD-student Thomas Leth Fink, Department of Oncology, Lillebaelt Hospital



Scheduled update

November 2023


For any further questions, please contact Centre for Shared Decision Making.

Users logged into a regional network can access the draft decision aid (pdf)

Based on IPDAS criteria (International Patient Decision Aid Standards) this decision aid (and/or supporting materials) meets:  

Six of six qualifying criteria are met

This Patient Decision Aid meets the IPDAS qualifying criteria to be defined as a Patient Decision Aid

Five of Five certifying criteria are met

Certifying criteria lower the risk of making a biased decision

Fourteen of seventeen quality criteria are met 

Quality criteria that strengthen the quality of the Patient Decision Aid


Only applicable criteria are included in the assessment